• P. N. Patsalos


Lacosamide (Fig. 1) corresponds chemically to (R)-2-acetamido-N-benzyle-3-methoxypropramide with an empirical formula of C13H18N2O3 and a molecular weight of 250.29.


Lamotrigine Topiramate Pregabalin Levetiracetam Neurotoxicity 


  1. 1. 
    Cawello W, Nickel B, Eggert-Formella A. No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers. J Clin Pharmacol. 2010;50:459–71.PubMedCrossRefGoogle Scholar
  2. 2. 
    Novy J, Patsalos PN, Sander JW, Sisodiya SM. Lacosamide neurotoxicity associated with concomitant use of sodium-blocking antiepileptic drugs: a pharmacodynamic interaction? Epilepsy Behav. 2011;20:20–3.PubMedCrossRefGoogle Scholar
  3. 3. 
    Thomas D, Scharfenecker U, Schiltmeyer B, Doty P, Cawello W, Horstmann R. Low potential for drug-drug interactions of lacosamide. Epilepsia. 2006;47 (Suppl 4):200.Google Scholar
  4. 4. 
    Nickel B, Zisowsky J, Cawello W, Lovern M, Sargentini-Maier ML. Population pharmacokinetics of LCM in subjects with partial-onset seizures: Results from two Phase III trials. J Clin Pharmacol. 2008;48: 1129.Google Scholar
  5. 5. 
    Cawello W, Bonn R. No pharmacokinetic interaction between lacosamide and valproic acid in healthy volunteers. J Clin Pharmacol. 2012;52:1739–48.Google Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • P. N. Patsalos
    • 1
    • 2
  1. 1.UCL-Institute of Neurology Department of Clinical and Experimental EpilepsyLondonLondon
  2. 2.Epilepsy Society Chalfont Centre for EpilepsyBuckinghamshireUK

Personalised recommendations